MELINTA THERAPEUTICS, INC. /NEW/ Increase (Decrease) in Inventories
MELINTA THERAPEUTICS, INC. /NEW/ reported Increase (Decrease) in Inventories of -$1.75 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2019-11-12
- MELINTA THERAPEUTICS, INC. /NEW/ increase (decrease) in inventories for the quarter ending 2019-09-30 was -$2.81M, a 144.94% decline year-over-year.
- MELINTA THERAPEUTICS, INC. /NEW/ increase (decrease) in inventories for the quarter ending 2019-06-30 was -$2.03M, a 177.42% decline year-over-year.
- MELINTA THERAPEUTICS, INC. /NEW/ increase (decrease) in inventories for the quarter ending 2019-03-31 was $3.09M, a 54.50% increase year-over-year.
- MELINTA THERAPEUTICS, INC. /NEW/ increase (decrease) in inventories for the quarter ending 2018-12-31 was $6.67M, a 38.13% increase year-over-year.
- MELINTA THERAPEUTICS, INC. /NEW/ increase (decrease) in inventories for fiscal 2018 was $17.54M, a 62.04% increase from fiscal 2017.
- MELINTA THERAPEUTICS, INC. /NEW/ increase (decrease) in inventories for fiscal 2017 was $10.82M.
- MELINTA THERAPEUTICS, INC. /NEW/ increase (decrease) in inventories for fiscal 2016 was $0.00.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|---|
| 2019-09-30 | -$2.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$4.84M derived: sum of 2 quarters · filed 2019-11-12 | -$1.75M 10-Q · filed 2019-11-12 | $4.92M derived: sum of 4 quarters · filed 2019-11-12 | |
| 2019-06-30 | -$2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.06M 10-Q · filed 2019-08-09 | $7.73M derived: sum of 3 quarters · filed 2019-08-09 | $13.97M derived: sum of 4 quarters · filed 2019-11-12 | |
| 2019-03-31 | $3.09M 10-Q · filed 2019-05-10 | $9.76M derived: sum of 2 quarters · filed 2019-05-10 | $16.01M derived: sum of 3 quarters · filed 2019-11-12 | $18.63M derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-12-31 | $6.67M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $12.91M derived: sum of 2 quarters · filed 2019-11-12 | $15.54M derived: sum of 3 quarters · filed 2019-11-12 | $17.54M 10-K · filed 2019-03-14 | |
| 2018-09-30 | $6.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $8.87M derived: sum of 2 quarters · filed 2019-11-12 | $10.87M 10-Q · filed 2019-11-12 | $15.70M derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | $2.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $4.63M 10-Q · filed 2019-08-09 | $2.10M 10-Q · filed 2018-08-09 | $9.46M derived: sum of 3 quarters · filed 2019-08-09 | $14.90M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $2.00M 10-Q · filed 2019-05-10 | $6.83M derived: sum of 2 quarters · filed 2019-05-10 | $12.28M derived: sum of 3 quarters · filed 2019-05-10 | ||
| 2017-12-31 | $4.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $10.27M derived: sum of 2 quarters · filed 2019-03-14 | $10.82M 10-K · filed 2019-03-14 | ||
| 2017-09-30 | $5.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $6.00M 10-Q · filed 2018-11-07 | |||
| 2017-06-30 | $551.00K 10-Q · filed 2018-08-09 | ||||
| 2016-12-31 | $0.00 10-K · filed 2019-03-14 |